BTC $63,075.66 +0.42%
ETH $1,882.75 +0.28%
BNB $609.91 +0.61%
XRP $1.00 +0.62%
SOL $75.59 +0.61%
TRX $0.3312 -0.34%
DOGE $0.0699 +0.35%
ADA $0.1776 -0.60%
BCH $203.82 +0.11%
LINK $9.57 +7.18%
HYPE $57.07 +2.44%
AAVE $86.55 +1.20%
SUI $0.6801 +0.61%
XLM $0.1586 +0.10%
ZEC $489.29 -0.14%
BTC $63,075.66 +0.42%
ETH $1,882.75 +0.28%
BNB $609.91 +0.61%
XRP $1.00 +0.62%
SOL $75.59 +0.61%
TRX $0.3312 -0.34%
DOGE $0.0699 +0.35%
ADA $0.1776 -0.60%
BCH $203.82 +0.11%
LINK $9.57 +7.18%
HYPE $57.07 +2.44%
AAVE $86.55 +1.20%
SUI $0.6801 +0.61%
XLM $0.1586 +0.10%
ZEC $489.29 -0.14%

Public company Leap Therapeutics completes $58,888,888 private placement to initiate digital asset financial strategy

2025-10-09 19:13:53

ChainCatcher news, biotechnology company Leap Therapeutics (NASDAQ: LPTX) announced that it has completed the previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to initiate its digital asset financial strategy.

Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy.

app_icon
ChainCatcher Building the Web3 world with innovations.